A method for determining whether or not the patient belongs to the good prognosis group after cancer treatment, and a method for determining whether or not the patient belongs to the juvenile cancer risk group.

摘要

A method for determining whether a subject belongs to a good prognosis group after cancer treatment by identifying a gene polymorphism in exon 5 of the subject's MICA gene, and identifying a gene polymorphism in exon 5 of the subject's MICA gene. Provides a method for determining whether a subject belongs to the juvenile cancer development risk group.